期刊文献+

中西医结合治疗慢性阻塞性肺疾病急性加重期临床研究 被引量:4

Clinical Study of Integrated Chinese and Western Medicine Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 目的:观察中西医结合治疗慢性阻塞性肺疾病急性加重期(AECOPD)患者的临床疗效。方法:将220例AECOPD气虚痰瘀证患者根据随机配对原则分为观察组与对照组各110例,2组均给予常规治疗,对照组服用孟鲁司特钠咀嚼片治疗,观察组以益气化痰祛瘀方联合孟鲁司特钠咀嚼片治疗,2组疗程均为1月。观察2组的疗效与心肺功能、免疫功能的变化情况。结果:对照组与观察组的总有效率分别为83.6%、96.4%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组左室射血分数、第1 s用力呼气容积占预计值百分比均高于治疗前(P<0.05),观察组2项指标值均高于对照组(P<0.05)。2组CD4^+水平均较治疗前升高(P<0.05),观察组CD4+水平与对照组比较,差异有统计学意义(P<0.05)。结论:中西医结合治疗AECOPD能改善患者的心肺功能和免疫功能,有利于提高疗效与生活质量。 Objective : To observe the clinical effect of integrated Chinese and western medicine therapy in treating patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Methods: Divided 220 cases of AECOPD patients with qi deficiency and phlegm stagnation syndrome into the observation group and the control group randomly, 110 cases in each group. Both groups were given routine treatment. The control group was treated with montelukast sodium chewable tablets, while the observation group was given prescription with the effect of invigorating qi and removing blood stasis, resoliving phlegm, combined with montelukast sodium chewable tablets. The two groups were both treated and observed for one month. Observed the curative effect and changes of pulmonary function and immune function in two groups. Results: The total effective rate was 83. 6 % in the control group and 96. 4 % in the observation group, the significant difference being found in the comparison between two groups(P 〈 0. 05). After treatment, the left ventricular ejection fraction and the forced expired volume in one second in two groups were higher than those before treatment(P 〈 0. 05), and these two indexes in the observation group were both higher than those in the control group(P〈 0. 05). Levels of CD4~+ in both groups were increased after treatment(P 〈 0. 05). Compared the level of CD4+ in the observation group with that in the control group, difference was significant(P 〈 0. 05). Conclusion : Integrated Chinese and western medicine therapy for AECOPD can improve cardiopulmonary function and immune function and enhance the curative effect and life quality, which is of high application value.
作者 吴献珍
出处 《新中医》 CAS 2017年第2期32-35,共4页 New Chinese Medicine
关键词 慢性阻塞性肺疾病急性加重期(AECOPD) 气虚痰瘀证 中西医结合疗法 益气化痰祛瘀方 孟鲁司特钠咀嚼片 心肺功能 免疫功能 Acute exacerbation of chronic obstructive pulmonary disease(AECOPD) Qi deficiency and phlegm stagnation syndrome Integrated Chinese and western medicine therapy Invigorating qi Removing blood stasis and resoliving phlegm Montelukast sodium chewable tablets Cardiopulmonary function Immune function
  • 相关文献

参考文献4

二级参考文献39

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 2黄文东.实用中医内科学[M].上海:上海科学技术出版社,1985.405-413. 被引量:101
  • 3中华人民共和国卫生部主编.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:127-128. 被引量:469
  • 4Lash TL,Johansen MB,Christensen S,et al. Hospitalization rates and survival associated with COPD : a nationwide Danish cohort study [J].Lung, 2011,189 ( 1 ) : 27-35. 被引量:1
  • 5Crump C, Sundquist K, Sundquist J, et al. Sociodemographic, psychiatric and somatic risk factors for suicide : a Swedish na- tional cohort study [ J ]. Psychol Med, 2014,44 (2) : 279-289. 被引量:1
  • 6Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD : a summa- ry the ATS/ERS position paper [ J ]. Eur Respir J, 2006,27 (1):242. 被引量:1
  • 7Mikami M, Llewellyn-Jones CG, Bayley D, et al. The chemo- tactic activity of sputum from patients with bronchiectasis [J ] Am J Respir Crit Care Med, 1998,157:723-725. 被引量:1
  • 8Barczyk A, Pierzchala W, Sozanska E. Interleukin-17 in spu- tum correlates with airway hyperresponsiveness to metha- choline [ J ]. Respir Med, 2003,97 (6) : 726-733. 被引量:1
  • 9中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修正版)[s].中华结核和呼吸杂志,2007,30(4):8. 被引量:1
  • 10Tsai CL, Sobrino JA, Camargo CA Jr. National study of emergen- cy department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993 - 2005 [J]. Acad Emerg Med, 2008, 15(12) :1275 - 1283. 被引量:1

共引文献115

同被引文献38

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部